The National Institute on Drug Abuse (NIDA) Clinical Trials Network has unveiled a new scientifically validated, online screening tool designed to assess a patient’s risk for substance misuse and substance use disorder, and assist the health care provider with prevention and treatment strategies. The Tobacco, Alcohol, Prescription medication, and other Substance use (TAPS) Tool is available on the NIDAMED Web Portal and consists of a comprehensive screening component followed by a brief assessment for those who screen positive. NIDAMED disseminates science-based resources to health professionals on the causes and consequences of drug use and addiction, and advances in pain management. NIDA is part of the National Institutes of Health.

The TAPS tool may either be self-administered by an adult patient (under medical supervision) or conducted as an interview by a health professional, but not intended to guide self-assessment or take the place of a health care provider’s clinical judgment. TAPS is one of several tools on the NIDAMED portal that can help providers quickly and easily introduce brief, evidence-based substance use screenings into their clinical practices. Clinicians can survey the tools available to determine which one best fits their practice.taps-image-web

For more information about the TAPS tool, go to: TAPS: Tobacco, Alcohol, prescription medication and other Substance Use Tool or https://www.drugabuse.gov/taps/#/.

For a more comprehensive list of evidence based screening tools, go to: Chart of Evidence-Based Screening Tools for Adults and Adolescents.

For more information on the NIDAMED initiative, go to: NIDAMED: Medical & Health Professionals

For more information, contact the NIDA press office at media@nida.nih.gov or 301-443-6245. Follow NIDA on Twitter and Facebook.